121895-45-2

Basic information

• Product Name: 3-[(2R,3S)-2-Bromo-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionyl]-4-isopropyl-oxazolidin-2-one
• Synonyms: 3-[(2R,3S)-2-Bromo-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionyl]-4-isopropyl-oxazolidin-2-one
• CAS NO: 121895-45-2
• Molecular Weight: 588.501
• Mol File: 121895-45-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-[(2R,3S)-2-Bromo-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionyl]-4-isopropyl-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(2R,3S)-2-Bromo-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionyl]-4-isopropyl-oxazolidin-2-one(121895-45-2)
• EPA Substance Registry System: 3-[(2R,3S)-2-Bromo-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionyl]-4-isopropyl-oxazolidin-2-one(121895-45-2)

Safety Data

• Hazardous Substances Data: 121895-45-2(Hazardous Substances Data)

Upstream product

• 141243-32-5 C₁₆H₂₉BBrNO₃ 
• 33016-47-6 (1-tritylimidazol-4-yl)carboxaldehyde 
• 121895-44-1 (R)-3-bromoacetyl-4-isopropyl-1,3-oxazolidin-2-one 
• 160054-11-5 3-(2-Bromo-acetyl)-4-isopropyl-oxazolidin-2-one 

Downstream Products

• 141243-36-9 (2S,3R)-2-Amino-3-((2S,3S,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-3-(1-trityl-1H-imidazol-4-yl)-propionic acid methyl ester 
• 142582-33-0 erythro-N^?-Triphenylmethyl-β-hydroxy-L-histidinmethylester 
• 141243-34-7 (2S,3R)-2-Azido-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionic acid methyl ester 
• 121895-46-3 (2'S,3'R,4R)-3-[2'-azido-3'-hydroxy-3'-(N-(triphenylmethyl)imidazol-4''-yl)propanoyl]-4-isopropyl-2-oxazolidinone 
• 160054-29-5 N^α-((benzyloxy)carbonyl)-N^im-(triphenylmethyl)-erythro-β-hydroxy-L-histidine methyl ester 
• 160054-27-3 3-<2'-(2'''-((N-(4''(R)-((N^α((tert-butyloxy)carbonyl)-N^im(triphenylmethyl)-erythro-β-hydroxy-L-histidyl)amino)-3''(S)-hydroxy-2''-(S)-methylpentanoyl)-L-threonyl)amino)ethyl)-2,4'-bithiazole-4-carboxamido>propyl methyl sulfide 
• 160054-25-1 (2S,3R)-2-tert-Butoxycarbonylamino-3-hydroxy-3-(1-trityl-1H-imidazol-4-yl)-propionic acid 
• 160054-24-0 erythro-N^4a-((tert-butyloxy)carbonyl)-N^im-(triphenylmethyl)-β-hydroxy-L-histidine methyl ester 
• 141243-31-4 N^α-((benzyloxy)carbonyl)-erythro-β-hydroxy-L-histidine methyl ester 
• 101485-34-1 N^α-(benzyloxycarbonyl)-erythro-β-hydroxy-L-histidine 

Relevant articles and documents

Synthesis of Tri- and Tetrapeptide S: The Extended C-Terminus of Bleomycin A2

Concise diastereocontrolled syntheses of tri- and tetrapeptide S, key subunits of the antitumor antibiotic bleomycin A2, are detailed.

A SYNTHETIC MODEL APPROACH TO THE SUGAR MOIETY OF BLEOMYCIN

In order to investigate the role of the sugar moiety of antitumor antibiotic bleomycin, glycosylation of erythro-β-hydroxy-L-histidine derivative is examined and several glycosylated model compounds are prepared by the chloroacetimidate method.These model